ColoAd1 1003 A Phase I multicenter, open label study of enadenotucirev combined with PD-1 inhibitor in subjects with metastatic or advanced epithelial tumors

July 19, 2018
https://clinicaltrials.gov/ct2/show/NCT02636036
Cancer - Brain, Solid Tumors
Principal Investigator: Ding Wang, MD
Metastatic or advanced epithelial tumors, brain cancer, cancer, epithelial tumors
Accepting Participants